NO20040203L - Kjemiske forbindelser - Google Patents

Kjemiske forbindelser

Info

Publication number: NO20040203L
Authority: NO; Norway
Prior art keywords: formula; chemical connections; corticotropin; crf; prodrugs
Prior art date: 2001-07-17

Application number

NO20040203A

Other languages

English (en)

Norwegian (no)

Inventor

Yves St-Denis

Romano Di Fabio

Collin F Regan

Michael K Schwaebe

Fabrizio Micheli

Original Assignee

Neurocrine Biosciences Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-07-17

Filing date

2004-01-16

Publication date

2004-03-16

2004-01-16 Application filed by Neurocrine Biosciences Inc filed Critical Neurocrine Biosciences Inc

2004-03-16 Publication of NO20040203L publication Critical patent/NO20040203L/no

Links

102000012289 Corticotropin-Releasing Hormone Human genes 0.000 abstract 2
108010022152 Corticotropin-Releasing Hormone Proteins 0.000 abstract 2
239000000055 Corticotropin-Releasing Hormone Substances 0.000 abstract 2
230000001404 mediated effect Effects 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
239000000651 prodrug Substances 0.000 abstract 1
229940002612 prodrug Drugs 0.000 abstract 1
150000003222 pyridines Chemical class 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
239000012453 solvate Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/16—Peri-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
Pulmonology (AREA)
Dermatology (AREA)
Otolaryngology (AREA)
Rheumatology (AREA)
Diabetes (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Vascular Medicine (AREA)
Anesthesiology (AREA)
Immunology (AREA)
Urology & Nephrology (AREA)
Endocrinology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Treatment Of Liquids With Adsorbents In General (AREA)
External Artificial Organs (AREA)

NO20040203A 2001-07-17 2004-01-16 Kjemiske forbindelser NO20040203L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0117395.4A GB0117395D0 (en)	2001-07-17	2001-07-17	Chemical compounds
PCT/US2002/022394 WO2003008414A1 (en)	2001-07-17	2002-07-15	Chemical compounds

Publications (1)

Publication Number	Publication Date
NO20040203L true NO20040203L (no)	2004-03-16

Family

ID=9918654

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20040203A NO20040203L (no)	2001-07-17	2004-01-16	Kjemiske forbindelser

Country Status (20)

Country	Link
EP (1)	EP1425281B1 (es)
JP (1)	JP2004537555A (es)
KR (1)	KR20040027880A (es)
CN (1)	CN1541217A (es)
AT (1)	ATE316972T1 (es)
AU (1)	AU2002354916B2 (es)
BR (1)	BR0211220A (es)
CA (1)	CA2452009A1 (es)
DE (1)	DE60209014T2 (es)
ES (1)	ES2256506T3 (es)
GB (1)	GB0117395D0 (es)
HU (1)	HUP0400460A2 (es)
IL (1)	IL159521A0 (es)
MX (1)	MXPA04000492A (es)
NO (1)	NO20040203L (es)
NZ (1)	NZ530508A (es)
PL (1)	PL367965A1 (es)
RU (1)	RU2004104464A (es)
WO (1)	WO2003008414A1 (es)
ZA (1)	ZA200309942B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2002249474B2 (en)	2001-04-30	2006-01-12	Glaxo Group Limited	Crf receptor antagonists
DE60215637T2 (de)	2001-05-21	2007-08-23	Neurocrine Biosciences, Inc., San Diego	Tri- und tetraaza-acenaphthylen-derivate als crf-rezeptor-antagonisten
DE602008003055D1 (de) *	2007-05-31	2010-12-02	Nerviano Medical Sciences Srl	Zyklokondensierte Azaindole, die als Kinase-Hemmer wirken
JP5719840B2 (ja)	2009-06-08	2015-05-20	武田薬品工業株式会社	Ｊａｋの阻害剤としてのジヒドロピロロナフチリジノン化合物
RU2498986C2 (ru) *	2011-07-20	2013-11-20	Учреждение Российской Академии Наук Институт Проблем Химической Физики Ран (Ипхф Ран)	ТЕТРАЦИАНОЗАМЕЩЕННЫЕ 1,4,9b-ТРИАЗАФЕНАЛЕНЫ И СПОСОБ ИХ ПОЛУЧЕНИЯ
CN106279011A (zh) *	2016-08-16	2017-01-04	成都百事兴科技实业有限公司	一种2,4‑二羟基‑6‑甲基烟酸乙酯的制备方法
KR102462991B1 (ko) *	2020-11-02	2022-11-04	한국해양과학기술원	남극-유래 진균 균주 아크레모늄(Acremonium sp.) SF-7394에서 분리한 화합물 및 이를 포함하는 항염증, 항암 또는 항당뇨용 조성물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4605642A (en) *	1984-02-23	1986-08-12	The Salk Institute For Biological Studies	CRF antagonists
DK1129096T3 (da) *	1998-11-12	2003-09-15	Neurocrine Biosciences Inc	CRF-receptorantagonister og fremgangsmåder, der er relateret dertil
ES2180338T3 (es) *	1998-11-12	2003-02-01	Neurocrine Biosciences Inc	Antagonistas del receptor de crf y metodos relacionados.

2001
- 2001-07-17 GB GBGB0117395.4A patent/GB0117395D0/en not_active Ceased
2002
- 2002-07-15 JP JP2003513973A patent/JP2004537555A/ja active Pending
- 2002-07-15 EP EP02752340A patent/EP1425281B1/en not_active Expired - Lifetime
- 2002-07-15 BR BR0211220-5A patent/BR0211220A/pt not_active IP Right Cessation
- 2002-07-15 AU AU2002354916A patent/AU2002354916B2/en not_active Ceased
- 2002-07-15 RU RU2004104464/04A patent/RU2004104464A/ru not_active Application Discontinuation
- 2002-07-15 WO PCT/US2002/022394 patent/WO2003008414A1/en not_active Ceased
- 2002-07-15 ES ES02752340T patent/ES2256506T3/es not_active Expired - Lifetime
- 2002-07-15 KR KR10-2004-7000714A patent/KR20040027880A/ko not_active Withdrawn
- 2002-07-15 CA CA002452009A patent/CA2452009A1/en not_active Abandoned
- 2002-07-15 MX MXPA04000492A patent/MXPA04000492A/es active IP Right Grant
- 2002-07-15 CN CNA02815746XA patent/CN1541217A/zh active Pending
- 2002-07-15 DE DE60209014T patent/DE60209014T2/de not_active Expired - Fee Related
- 2002-07-15 PL PL02367965A patent/PL367965A1/xx not_active Application Discontinuation
- 2002-07-15 HU HU0400460A patent/HUP0400460A2/hu unknown
- 2002-07-15 AT AT02752340T patent/ATE316972T1/de not_active IP Right Cessation
- 2002-07-15 IL IL15952102A patent/IL159521A0/xx unknown
- 2002-07-15 NZ NZ530508A patent/NZ530508A/en unknown
2003
- 2003-12-23 ZA ZA200309942A patent/ZA200309942B/xx unknown
2004
- 2004-01-16 NO NO20040203A patent/NO20040203L/no unknown

Also Published As

Publication number	Publication date
EP1425281A1 (en)	2004-06-09
WO2003008414A1 (en)	2003-01-30
CN1541217A (zh)	2004-10-27
NZ530508A (en)	2005-11-25
EP1425281B1 (en)	2006-02-01
BR0211220A (pt)	2004-07-13
PL367965A1 (en)	2005-03-07
ES2256506T3 (es)	2006-07-16
HUP0400460A2 (hu)	2005-01-28
ATE316972T1 (de)	2006-02-15
KR20040027880A (ko)	2004-04-01
RU2004104464A (ru)	2005-08-10
JP2004537555A (ja)	2004-12-16
ZA200309942B (en)	2004-05-25
DE60209014T2 (de)	2006-07-13
IL159521A0 (en)	2004-06-01
AU2002354916B2 (en)	2006-10-19
MXPA04000492A (es)	2005-03-07
GB0117395D0 (en)	2001-09-05
CA2452009A1 (en)	2003-01-30
DE60209014D1 (de)	2006-04-13

Publication	Publication Date	Title
CY1107747T1 (el)	2013-04-18	Υποκατεστημενα τετρακυκλικα παραγωγα πυρρολοκινολονης χρησιμα ως αναστολεις της φωσφοδιεστερασης
NO20035583D0 (no)	2003-12-15	Imidazo` 1,2-A pyridinderivater for profylakse og behandling av herpes virale infeksjoner
UY27431A1 (es)	2003-03-31	Compuestos químicos
UY27435A1 (es)	2003-04-30	Compuestos químicos
NO20032829D0 (no)	2003-06-20	Kjemiske forbindelser
GB0121621D0 (en)	2001-10-31	Chemical compounds
ATE296826T1 (de)	2005-06-15	Pyrazolo(1,5)pyridinderivate
TW200602036A (en)	2006-01-16	Diphenylazetidone derivates
NO20082496L (no)	2008-07-24	Pyrazinderivater
DE602004005960D1 (de)	2007-05-31	Heteroaryl-substituierte pyrrolä2, 3- büpyridin-derivate als crf-rezeptor-antagonisten
DE60212949D1 (de)	2006-08-17	Antivirale pyrazolopyridin verbindungen
MXPA05012247A (es)	2006-02-10	Derivados de bencimidazol nuevos.
MXPA04000814A (es)	2004-05-21	Derivados de 2h-piridazina-3-ona novedosos, composiciones farmaceuticas que contienen a los mismos y un procedimiento para la preparacion del ingrediente activo.
DE60211539D1 (de)	2006-06-22	Imidazopyridinderivate zur verwendung bei der behandlung von herpes-vireninfektion
ATE300541T1 (de)	2005-08-15	Pyrazolopyridinderivate
SE0302139D0 (sv)	2003-07-28	Novel compounds
NO20040206L (no)	2004-03-16	Kjemiske forbindelser
BR0318521A (pt)	2006-09-12	arilindenopiridinas e arilindenopirimidinas e métodos terapêuticos e profiláticos relacionados
SE0303280D0 (sv)	2003-12-05	Novel compounds
ZA200309942B (en)	2004-05-25	Chemical compounds.
DE60222465D1 (de)	2007-10-25	Pyrazolopyridin-derivate als antiherpesmittel
ATE274515T1 (de)	2004-09-15	Pyrazolopyridinderivate
ATE397609T1 (de)	2008-06-15	Corticotropinfreisetzungsfaktor antagonisten
SE9904128D0 (sv)	1999-11-15	Novel compounds
SG146685A1 (en)	2008-10-30	Dihydroporphine derivatives, processes for their preparation, and pharmaceutical compositions containing them